X

LSD Clinical Trials

34 record(s) found.

Entheogen: lysergic acid diethylamide
Study Title: Minidosing Lysergic Acid Diethylamide (LSD) for Chronic Cluster Headache
Start Date: May 01, 2023 - Last Update: August 1, 2022
Conditions: Chronic Cluster Headache
Location(s):
Source: clinicaltrials.gov
short summary

Entheogen: lysergic acid diethylamide
Study Title: ACT for Methamphetamine Use Disorder in Women and Gender Non-Conforming Individuals
Start Date: Jan 01, 2023 - Last Update: July 26, 2022
Conditions: Methamphetamine Abuse, Methamphetamine-dependence
Location(s): Canada
Source: clinicaltrials.gov
short summary

Entheogen: lysergic acid diethylamide
Study Title: LSD Treatment for Persons With Alcohol Use Disorder
Start Date: Jan 01, 2023 - Last Update: July 26, 2022
Conditions: Alcohol Use Disorder (AUD)
Location(s): Switzerland
Source: clinicaltrials.gov
short summary

Entheogen: lysergic acid diethylamide
Study Title: LSD Base and LSD Tartrate Bioequivalence and Bioavailability in Healthy Subjects
Start Date: Mar 17, 2022 - Last Update: March 31, 2022
Conditions: Healthy
Location(s): Switzerland
Source: clinicaltrials.gov
short summary

Entheogen: lysergic acid diethylamide
Study Title: Effects of SERT Inhibition on the Subjective Response to LSD in Healthy Subjects
Start Date: Mar 01, 2022 - Last Update: January 3, 2022
Conditions: Healthy
Location(s): Switzerland
Source: clinicaltrials.gov
short summary

Entheogen: lysergic acid diethylamide
Study Title: Effects of LSD on Neuroplasticity in Healthy Subjects
Start Date: Feb 01, 2022 - Last Update: January 4, 2022
Conditions: Healthy
Location(s): Switzerland
Source: clinicaltrials.gov
short summary

Entheogen: lysergic acid diethylamide
Study Title: Safety and Efficacy of Low Dose MM-120 for ADHD Proof of Concept Trial
Start Date: Dec 17, 2021 - Last Update: June 21, 2022
Conditions: ADHD, Attention Deficit Disorder
Location(s): Netherlands, Switzerland
Source: clinicaltrials.gov
short summary

Entheogen: lysergic acid diethylamide
Study Title: Safety and efficacy of repeated low dose D-lysergic acid diethylamide (LSD) D-Tartrate (MM-120) as treatment for ADHD in adults: a multi-center, randomized, double- blind, placebo-controlled Phase ...
Start Date: Nov 24, 2021
Conditions: Attention-Deficit/Hyperactivity Disorder
Location(s): Netherlands
Source: www.clinicaltrialsregister.eu
short summary

Entheogen: lysergic acid diethylamide
Study Title: Role of the Serotonin 5-HT2A Receptor in Mescaline-induced Altered States of Consciousness
Start Date: Aug 11, 2021 - Last Update: August 18, 2021
Conditions: Healthy
Location(s): Switzerland
Source: clinicaltrials.gov
short summary

Entheogen: lysergic acid diethylamide
Study Title: A randomised, double-blind, placebo-controlled trial of repeated microdoses of lysergic acid diethylamide (LSD) in healthy volunteers
Start Date: Jan 05, 2021
Conditions: Major depressive disorder
Location(s): New Zealand
Source: anzctr.org.au
short summary

Entheogen: lysergic acid diethylamide
Study Title: Effects of MDMA Co-administration on the Response to LSD in Healthy Subjects
Start Date: Jan 01, 2021 - Last Update: September 8, 2021
Conditions: Healthy
Location(s): Switzerland
Source: clinicaltrials.gov
short summary

Entheogen: lysergic acid diethylamide
Study Title: Effect of Ketanserin After LSD Administration
Start Date: Oct 16, 2020 - Last Update: October 21, 2021
Conditions: Healthy
Location(s): Switzerland
Source: clinicaltrials.gov
short summary

Entheogen: lysergic acid diethylamide
Study Title: The Canadian Underage Substance Use Prevention Trial
Start Date: Dec 01, 2019 - Last Update: December 17, 2019
Conditions: Substance Use Disorders, Adolescent Behavior, Adolescent Development
Location(s): Canada
Source: clinicaltrials.gov
short summary

Entheogen: lysergic acid diethylamide
Study Title: LSD Therapy for Persons Suffering From Major Depression
Start Date: Nov 01, 2019 - Last Update: May 25, 2022
Conditions: Major Depressive Disorder
Location(s): Switzerland
Source: clinicaltrials.gov
short summary

Entheogen: lysergic acid diethylamide
Study Title: Dosing Intervals of Opioid Medication for Chronic Pain
Start Date: May 01, 2019 - Last Update: March 27, 2020
Conditions: Chronic Pain
Location(s): Canada
Source: clinicaltrials.gov
short summary

Entheogen: lysergic acid diethylamide
Study Title: Direct Comparison of Altered States of Consciousness Induced by LSD and Psilocybin
Start Date: Mar 27, 2019 - Last Update: April 27, 2021
Conditions: Healthy
Location(s): Switzerland
Source: clinicaltrials.gov
short summary

Entheogen: lysergic acid diethylamide
Study Title: Lysergic Acid Diethylamide (LSD) as Treatment for Cluster Headache
Start Date: Jan 02, 2019 - Last Update: May 5, 2022
Conditions: Cluster Headache
Location(s): Switzerland
Source: clinicaltrials.gov
short summary

Entheogen: lysergic acid diethylamide
Study Title: Prevalence of New Psychoactive Substances Use
Start Date: Jan 01, 2019 - Last Update: October 5, 2018
Conditions: Addiction
Location(s):
Source: clinicaltrials.gov
short summary

Entheogen: lysergic acid diethylamide
Study Title: Mood Effects of Serotonin Agonists
Start Date: May 01, 2018 - Last Update: December 31, 2018
Conditions: Healthy
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: lysergic acid diethylamide
Study Title: Role of the Serotonin 5-HT2A Receptor in LSD-induced Altered States of Consciousness (LDR-Study)
Start Date: Nov 28, 2017 - Last Update: August 28, 2019
Conditions: Healthy
Location(s): Switzerland
Source: clinicaltrials.gov
short summary

Entheogen: lysergic acid diethylamide
Study Title: LSD Treatment in Persons Suffering From Anxiety Symptoms in Severe Somatic Diseases or in Psychiatric Anxiety Disorders
Start Date: Jun 23, 2017 - Last Update: December 22, 2021
Conditions: Patients, Anxiety Disorders
Location(s): Switzerland
Source: clinicaltrials.gov
short summary

Entheogen: lysergic acid diethylamide
Study Title: Differential Responses to Drugs and Sweet Tastes
Start Date: Feb 09, 2017 - Last Update: January 22, 2019
Conditions: Bipolar II Disorder
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: lysergic acid diethylamide
Study Title: Role of Dopamine, Serotonin and 5-HT2A Receptors in Emotion Processing
Start Date: Feb 01, 2017 - Last Update: October 15, 2018
Conditions: Healthy
Location(s): Switzerland
Source: clinicaltrials.gov
short summary

Entheogen: lysergic acid diethylamide
Study Title: A Double-blind, Placebo-controlled Study to Evaluate Very Low Dose LSD in Healthy Volunteers Aged 55-75 Years
Start Date: Jun 29, 2015 - Last Update: June 9, 2020
Conditions: Healthy Volunteers
Location(s):
Source: clinicaltrials.gov
short summary

Entheogen: lysergic acid diethylamide
Study Title: The Role of 5-HT2A Receptor in the Perception of Self and Personal Meaning in Healthy Volunteers
Start Date: Mar 01, 2015 - Last Update: February 1, 2016
Conditions: Healthy
Location(s): Switzerland
Source: clinicaltrials.gov
short summary

Entheogen: lysergic acid diethylamide
Study Title: Neuronal Correlates of Altered States of Consciousness
Start Date: Dec 01, 2014 - Last Update: September 25, 2015
Conditions: Healthy
Location(s): Switzerland
Source: clinicaltrials.gov
short summary

Entheogen: lysergic acid diethylamide
Study Title: Pilot Study of Entacapone for Methamphetamine Abuse
Start Date: Jun 01, 2014 - Last Update: September 12, 2019
Conditions: Methamphetamine Dependence
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: lysergic acid diethylamide
Study Title: Psychological, Physiological, Endocrine, and Pharmacokinetic Effects of LSD in a Controlled Study
Start Date: Jun 01, 2013 - Last Update: January 21, 2016
Conditions: Healthy
Location(s): Switzerland
Source: clinicaltrials.gov
short summary

Entheogen: lysergic acid diethylamide
Study Title: A Study to Assess the Abuse Potential of Hydrocodone Extended-Release Tablet in Recreational Opioid Users
Start Date: Mar 01, 2012 - Last Update: November 21, 2012
Conditions: Drug Abuse
Location(s): United States, Canada
Source: clinicaltrials.gov
short summary

Entheogen: lysergic acid diethylamide
Study Title: A Study To Evaluate The Abuse Potential Of Single Oral Doses Of Dimebon (Latrepirdine) In Healthy Recreational Polydrug Users
Start Date: Oct 01, 2009 - Last Update: April 2, 2013
Conditions: Alzheimer's Disease, Huntington's Disease
Location(s):
Source: clinicaltrials.gov
short summary

Entheogen: lysergic acid diethylamide
Study Title: Study to Evaluate the Relative Abuse Potential of Almorexant in Recreational Drug Users
Start Date: Sep 01, 2009 - Last Update: February 12, 2016
Conditions: Abuse Potential Study
Location(s):
Source: clinicaltrials.gov
short summary

Entheogen: lysergic acid diethylamide
Study Title: Abuse Potential of Sativex
Start Date: Feb 01, 2008 - Last Update: June 14, 2013
Conditions: Evaluation of Abuse Potential of Sativex
Location(s): Canada
Source: clinicaltrials.gov
short summary

Entheogen: lysergic acid diethylamide
Study Title: Lysergic Acid Diethylamide (LSD)-Assisted Psychotherapy in People With Illness-related Anxiety
Start Date: Feb 01, 2008 - Last Update: July 6, 2022
Conditions: Anxiety
Location(s): Switzerland
Source: clinicaltrials.gov
short summary

Entheogen: lysergic acid diethylamide
Study Title: A Clinical Study in Healthy Adults Who Sometimes Take Drugs for Pleasure Which Aims to Evaluate Whether GRT0151Y is Likely to be Abused
Start Date: Jun 21, 2007 - Last Update: December 7, 2018
Conditions: Pain, Acute Pain
Location(s): Canada
Source: clinicaltrials.gov
short summary